Spirulina for Liver Protection and Regeneration in Hepatectomy Patients

This clinical trial aims to investigate whether spirulina, a type of algae often used as a dietary supplement, can help protect the liver and aid in its recovery following a partial hepatectomy, which is a surgery to remove part of the liver. The study focuses on patients undergoing this surgery to see if spirulina can improve liver function, promote regeneration, and reduce inflammation. Understanding the safety of spirulina in this context is also a key component. The findings from this study could lead to new ways to support liver recovery in patients with liver diseases or those undergoing liver surgery, potentially improving outcomes and reducing complications. Participants in the study will be asked to take tablets containing either spirulina or a placebo for three weeks before and three weeks after their surgery. They will also provide blood and stool samples at various points to help researchers assess changes in liver function. Additionally, a small piece of liver tissue, collected during surgery, will be analyzed to provide further insights. Regular clinic visits will ensure participants' safety and allow for continuous monitoring of their health. The study evaluates liver function by measuring changes in specific liver enzymes and bilirubin levels, comparing results between the spirulina and placebo groups. This approach helps determine if spirulina has a beneficial effect on liver health during the recovery process.